139 related articles for article (PubMed ID: 2419453)
1. Determination of antibody-complement mediated cytotoxicity using ATP release induced by a monoclonal antibody against the Burkitt lymphoma associated globotriaosylceramide antigen.
Wils P; Junqua S; Le Pecq JB
J Immunol Methods; 1986 Mar; 87(2):217-22. PubMed ID: 2419453
[TBL] [Abstract][Full Text] [Related]
2. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody.
Nudelman E; Kannagi R; Hakomori S; Parsons M; Lipinski M; Wiels J; Fellous M; Tursz T
Science; 1983 Apr; 220(4596):509-11. PubMed ID: 6836295
[TBL] [Abstract][Full Text] [Related]
3. Comparison of inhibitory effect of galactose analogs on the binding and cytotoxicity of an anti-globotriaosylceramide monoclonal antibody coupled or not coupled to pokeweed antiviral protein.
Junqua S; Wils P; Mishal Z; Le Pecq JB
Eur J Immunol; 1987 Apr; 17(4):459-64. PubMed ID: 2436922
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines.
Wiels J; Holmes EH; Cochran N; Tursz T; Hakomori S
J Biol Chem; 1984 Dec; 259(23):14783-7. PubMed ID: 6438103
[TBL] [Abstract][Full Text] [Related]
5. [A monoclonal antibody, specific for Burkitt's lymphoma, is also a blood group Pk antibody].
Fellous M; Wiels J; Cartron JP; Tursz T
Dev Biol Stand; 1984; 57():293-8. PubMed ID: 6084615
[TBL] [Abstract][Full Text] [Related]
6. Decreased accessibility of globotriaosylceramide associated with decreased tumorigenicity in Burkitt's lymphoma variants induced by immunoselection.
Junqua S; Larsen AK; Wils P; Mishal Z; Wiels J; Le Pecq JB
Cancer Res; 1989 Dec; 49(23):6480-6. PubMed ID: 2684394
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody against a Burkitt lymphoma associated antigen has an anti-Pk red blood cell specificity.
Fellous M; Cartron JP; Wiels J; Tursz T
Br J Haematol; 1985 Jul; 60(3):559-65. PubMed ID: 2410009
[TBL] [Abstract][Full Text] [Related]
8. IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells.
Czuczman MS; Garin-Chesa P; Lemoli RM; Scheinberg DA
Cancer Immunol Immunother; 1993 Jun; 36(6):387-96. PubMed ID: 8500111
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody against a Burkitt lymphoma-associated antigen.
Wiels J; Fellous M; Tursz T
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6485-8. PubMed ID: 7031655
[TBL] [Abstract][Full Text] [Related]
10. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
[TBL] [Abstract][Full Text] [Related]
11. Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected].
Kanda T; Yoshino H; Ariga T; Yamawaki M; Yu RK
J Cell Biol; 1994 Jul; 126(1):235-46. PubMed ID: 8027181
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a human monoclonal antibody probably detecting the leukocyte differentiation antigen CD39.
Ikewaki N; Takabe S; Tsuji K
Tissue Antigens; 1992 Apr; 39(4):174-81. PubMed ID: 1326791
[TBL] [Abstract][Full Text] [Related]
13. Identification of HSP-60 as the specific antigen of IgM produced by BRG-lymphoma cells.
Musante L; Ulivi M; Cutrona G; Chiorazzi N; Roncella S; Candiano G; Ferrarini M
Electrophoresis; 1999; 20(4-5):1092-7. PubMed ID: 10344290
[TBL] [Abstract][Full Text] [Related]
14. In vitro mimicry of CaMBr1 tumor-associated antigen by synthetic oligosaccharides.
Adobati E; Panza L; Russo G; Colnaghi MI; Canevari S
Glycobiology; 1997 Mar; 7(2):173-8. PubMed ID: 9134423
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome.
Roncella S; Cutrona G; Favre A; Ulivi M; Fais F; Signorini A; Grossi CE; Chiorazzi N; Ferrarini M
Blood; 1996 Jul; 88(2):599-608. PubMed ID: 8695808
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
[TBL] [Abstract][Full Text] [Related]
17. Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells.
Murray LJ; Habeshaw JA; Wiels J; Greaves MF
Int J Cancer; 1985 Nov; 36(5):561-5. PubMed ID: 3877000
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of human monoclonal IgM with nerve glycosphingolipids.
Hauttecoeur B; Schmitt C; Dubois C; Danon F; Brouet JC
Clin Exp Immunol; 1990 May; 80(2):181-5. PubMed ID: 1694117
[TBL] [Abstract][Full Text] [Related]
19. Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients.
Gazitt Y; Sammar M; Treves AJ; Manny N; Gurfel D; Polliack A
Immunol Lett; 1986 Mar; 12(2-3):101-8. PubMed ID: 3522412
[TBL] [Abstract][Full Text] [Related]
20. Canine lymphoma-associated antigens defined by murine monoclonal antibodies.
Steplewski Z; Jeglum KA; Rosales C; Weintraub N
Cancer Immunol Immunother; 1987; 24(3):197-201. PubMed ID: 3594482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
